Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

AstraZeneca Wins Two Approval Recommendations From EU Agency

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

Photo Credit :

1599724435_7ZCU1h_2020_09_10T065145Z_1_LYNXMPEG890H5_RTROPTP_4_HEALTH_CORONAVIRUS_ASTRAZENECA.JPG

The European medicines watchdog has recommended approving AstraZeneca Plc's treatments for a form of heart failure and a lung disorder, the British drugmaker said on Monday.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Forxiga for treating a form of heart failure and Trixeo Aerosphere for a form of lung disorder known as "smoker's lung".

(Reuters)


Tags assigned to this article:
astrazeneca drugmaker british CHMP